$9.88
+0.240 (+2.49%)
At Close: Jun 04, 2026
Earnings Scheduled For February 28, 2022
09:17am, Monday, 28'th Feb 2022 Benzinga
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ: LXRX ) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (NASDAQ: PRAX ) is likely to report earnings for its fourth quarter. • Blackstone Secured (NYSE: BXSL ) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million. • Mersana Therapeutics (NASDAQ: MRSN ) is estimated to report earnings for its fourth quarter. • Partner Communications Co (NASDAQ: PTNR ) is expected to report earnings for its fourth quarter. • Daqo New Energy (NYSE: DQ ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million. • Easterly Government Props (NYSE: DEA ) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million. • Aurinia Pharmaceuticals (NASDAQ: AUPH ) is expected to report earnings for its fourth quarter. • Kosmos Energy (NYSE: KOS ) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.
Dentsply International (XRAY) Misses Q4 Earnings and Revenue Estimates
09:14am, Monday, 28'th Feb 2022
Dentsply (XRAY) delivered earnings and revenue surprises of -3.80% and 3.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Dentsply Sirona Q4 2021 Earnings Preview
06:25pm, Friday, 25'th Feb 2022 Seeking Alpha
Dentsply Sirona (NASDAQ:XRAY) is scheduled to announce Q4 earnings results on Monday, February 28th, before market open.The consensus EPS Estimate is $0.79 (-9.2% Y/Y) and the consensus…
Should You Buy Dentsply Sirona (XRAY) Ahead of Earnings?
04:05pm, Friday, 25'th Feb 2022 Zacks Investment Research
Dentsply Sirona (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
On March 4, Dentsply Sirona, a pioneer in digital dentistry, will share details about the Company’s exciting collaboration with Google Cloud and a separate new 3D printing solution, Primeprint, in a
Should You Buy Dentsply Sirona (XRAY) Ahead of Earnings?
12:16pm, Friday, 25'th Feb 2022
Dentsply Sirona (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Dentsply Sirona: Clear Aligner Business Will Drive Growth
09:47am, Friday, 25'th Feb 2022
Dentsply Sirona: Clear Aligner Business Will Drive Growth
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
12:10am, Friday, 25'th Feb 2022 Zacks Investment Research
Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
12:45pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
CHARLOTTE, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that Dr. Dorothea Wenzel has been appointed to its Board of Directors (
DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?
12:06pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.
DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?
08:29am, Tuesday, 22'nd Feb 2022
DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.
Dentsply International (XRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
08:01pm, Monday, 21'st Feb 2022 Zacks Investment Research
Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN Healthcare (AMN) to Report Q4 Earnings: What's in Store?
03:09pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
AMN Healthcare's (AMN) fourth-quarter results are likely to reflect solid demand in some of the areas of its business.
OPKO Health (OPK) to Post Q4 Earnings: What's in the Cards?
04:53pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
OPKO Health's (OPK) fourth-quarter results are likely to reflect strength in Rayaldee.
What's in Store for West Pharmaceutical's (WST) Q4 Earnings?
04:52pm, Monday, 14'th Feb 2022 Zacks Investment Research
West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.
Sign In
Buy XRAY